Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Exchange Rate Effect (2020 - 2025)

Historic Exchange Rate Effect for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to -$2000.0.

  • RxSight's Exchange Rate Effect fell 12857.14% to -$2000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $6000.0, marking a year-over-year decrease of 4545.45%. This contributed to the annual value of -$9000.0 for FY2024, which is 25000.0% down from last year.
  • RxSight's Exchange Rate Effect amounted to -$2000.0 in Q3 2025, which was down 12857.14% from $14000.0 recorded in Q2 2025.
  • In the past 5 years, RxSight's Exchange Rate Effect registered a high of $14000.0 during Q4 2022, and its lowest value of -$12000.0 during Q4 2024.
  • For the 5-year period, RxSight's Exchange Rate Effect averaged around -$210.53, with its median value being -$2000.0 (2025).
  • As far as peak fluctuations go, RxSight's Exchange Rate Effect plummeted by 100000.0% in 2022, and later soared by 150000.0% in 2025.
  • RxSight's Exchange Rate Effect (Quarter) stood at -$3000.0 in 2021, then surged by 566.67% to $14000.0 in 2022, then plummeted by 42.86% to $8000.0 in 2023, then crashed by 250.0% to -$12000.0 in 2024, then skyrocketed by 83.33% to -$2000.0 in 2025.
  • Its Exchange Rate Effect stands at -$2000.0 for Q3 2025, versus $14000.0 for Q2 2025 and $6000.0 for Q1 2025.